Time to reconsider antibiotic prophylaxis in women with prolonged rupture of membranes: The trend of Enterobacteriaceae in peripartum infections.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 11 05 2023
received: 21 02 2023
accepted: 16 05 2023
medline: 15 11 2023
pubmed: 6 6 2023
entrez: 6 6 2023
Statut: ppublish

Résumé

The proportion of neonatal early-onset sepsis (EOS) by gram-negative bacteria has increased. The authors examined bacterial distribution in the amniotic membrane cultures of women with peripartum fever (PPF) and related perinatal outcomes. This retrospective study covered the period 2011 to 2019. The primary outcomes were Enterobacteriaceae-positive birth culture rates in women with PPF and the trend of ampicillin resistance. Maternal and neonatal outcomes were compared between women with group B Streptococcus (GBS) and Enterobacteriaceae-positive isolates. Bacterial distribution was also compared according to rupture of membrane (ROM) duration. Among 621 women with PPF, the positive birth culture rate was 52%. Increasing prevalences of ampicillin-resistant Enterobacteriaceae (81%) were noted. Positive birth cultures were associated with maternal bacteremia (P = 0.017) and neonatal EOS (P = 0.003). Prolonged ROM ≥18 h was associated with increased risk for Enterobacteriaceae-positive cultures, while intrapartum ampicillin and gentamicin were associated with lower risk. Enterobacteriaceae-positive compared with GBS-positive birth cultures were associated with adverse maternal and neonatal outcomes. Positive birth cultures were related to maternal bacteremia and neonatal sepsis. Adverse outcomes were more prevalent among women with Enterobacteriaceae-positive versus GBS-positive birth cultures. Prolonged ROM is a risk factor for Enterobacteriaceae-positive birth cultures among women with PPF. Antibiotic prophylaxis treatment for prolonged ROM should be reconsidered.

Identifiants

pubmed: 37278115
doi: 10.1002/ijgo.14899
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ampicillin 7C782967RD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

956-964

Informations de copyright

© 2023 International Federation of Gynecology and Obstetrics.

Références

Czikk MJ, McCarthy FP, Murphy KE. Chorioamnionitis: from pathogenesis to treatment. Clin Microbiol Infect. 2011;17(9):1304-1311. doi:10.1111/j.1469-0691.2011.03574.x
Olsen MA, Butler AM, Willers DM, Gross GA, Devkota P, Fraser VJ. Risk factors for endometritis after low transverse cesarean delivery. Infect Control Hosp Epidemiol. 2010;31(1):69-77. doi:10.1086/649018. Erratum in: Infect Control Hosp Epidemiol. 2013;34(7):767.
Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15-20. doi:10.1056/NEJM200001063420103
Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal infections and prematurity study group. Obstet Gynecol. 1991;77(4):604-610.
Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol. 2000;96(4):498-503. doi:10.1016/s0029-7844(00)00977-7
Prevention of group B streptococcal early-onset disease in newborns: ACOG committee opinion, number 797. Obstet Gynecol. 2020;135(2):e51-e72. doi:10.1097/AOG.0000000000003668. Erratum in: Obstet Gynecol. 2020;135(4):978-979.
Romero R, Gomez-Lopez N, Winters AD, et al. Evidence that intra-amniotic infections are often the result of an ascending invasion - a molecular microbiological study. J Perinat Med. 2019;47(9):915-931. doi:10.1515/jpm-2019-0297
Zhu L, Luo F, Hu W, et al. Bacterial communities in the womb during healthy pregnancy. Front Microbiol. 2018;9:2163. doi:10.3389/fmicb.2018.02163
Wolf MF, Miron D, Peleg D, et al. Reconsidering the current preterm premature rupture of membranes antibiotic prophylactic protocol. Am J Perinatol. 2015;32(13):1247-1250. doi:10.1055/s-0035-1552935
Montelongo EM, Blue NR, Lee RH. Placenta accreta in a woman with Escherichia coli chorioamnionitis with intact membranes. Case Rep Obstet Gynecol. 2015;2015:121864. doi:10.1155/2015/121864
Solomon S, Akeju O, Odumade OA, et al. Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. PLoS One. 2021;16(8):e0255410. doi:10.1371/journal.pone.0255410
Glikman D, Curiel N, Glatman-Freedman A, et al. Nationwide epidemiology of early-onset sepsis in Israel 2010-2015, time to re-evaluate empiric treatment. Acta Paediatr. 2019;108(12):2192-2198. doi:10.1111/apa.14889
Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Prevalence of early-onset neonatal infection among newborns of mothers with bacterial infection or colonization: a systematic review and meta-analysis. BMC Infect Dis. 2015;15:118. doi:10.1186/s12879-015-0813-3
Committee opinion no. 712: intrapartum management of intraamniotic infection. Obstet Gynecol. 2017;130(2):e95-e101. doi:10.1097/AOG.0000000000002236
Chmielarczyk A, Wójkowska-Mach J, Romaniszyn D, et al. Mode of delivery and other risk factors for Escherichia coli infections in very low birth weight infants. BMC Pediatr. 2014;14:274. doi:10.1186/1471-2431-14-274
Bhola K, Al-Kindi H, Fadia M, Kent AL, Collignon P, Dahlstrom JE. Placental cultures in the era of peripartum antibiotic use. Aust N Z J Obstet Gynaecol. 2008;48(2):179-184. doi:10.1111/j.1479-828X.2008.00833.x
Ward K, Theiler RN. Once-daily dosing of gentamicin in obstetrics and gynecology. Clin Obstet Gynecol. 2008;51(3):498-506. doi:10.1097/GRF.0b013e31818091cd
Raymond J, Lopez E, Bonacorsi S, et al. Evidence for transmission of Escherichia coli from mother to child in late-onset neonatal infection. Pediatr Infect Dis J. 2008;27(2):186-188. doi:10.1097/INF.0b013e31815b1b03
Surgers L, Valin N, Carbonne B, et al. Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum. Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):107-113. doi:10.1007/s10096-012-1724-5
Casey BM, Cox SM. Chorioamnionitis and endometritis. Infect Dis Clin North Am. 1997;11(1):203-222. doi:10.1016/s0891-5520(05)70349-4
Nigam A, Gupta N, Elahi AA, Jairajpuri ZS, Batra S. Delayed uterine necrosis: rare cause of nonhealing wound. J Clin Diagn Res. 2016;10(12):QD01-QD02. doi:10.7860/JCDR/2016/20943.9058
Tymon-Rosario J, Chuang M. Multidrug-resistant Escherichia coli resulting in postpartum necrotizing endomyometritis. Case Rep Obstet Gynecol. 2019;2019:6715974. doi:10.1155/2019/6715974
Bensal A, Weintraub AY, Levy A, Holcberg G, Sheiner E. The significance of peripartum fever in women undergoing vaginal deliveries. Am J Perinatol. 2008;25(9):567-572. doi:10.1055/s-0028-1085624
Sherman DJ, Tovbin J, Lazarovich T, et al. Chorioamnionitis caused by gram-negative bacteria as an etiologic factor in preterm birth. Eur J Clin Microbiol Infect Dis. 1997;16(6):417-423. doi:10.1007/BF02471905
Passos F, Cardoso K, Coelho AM, Graça A, Clode N, Mendes da Graça L. Antibiotic prophylaxis in premature rupture of membranes at term: a randomized controlled trial. Obstet Gynecol. 2012;120(5):1045-1051. doi:10.1097/aog.0b013e31826e46bc

Auteurs

Raneen Abu Shqara (R)

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Daniel Glikman (D)

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Saher Jad (S)

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.

Hagai Rechnitzer (H)

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.

Lior Lowenstein (L)

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Maya Frank Wolf (M)

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH